Global clinical technology company Wolters Kluwer Health announced it added generative AI capabilities to aid collaboration for its clinical decision support (CDS) solution UpToDate.
The platform, designed to offer evidence-based CDS, is viewed 1.7 million times a day by healthcare teams globally to help provide better care, Greg Samios, president and CEO of clinical effectiveness at Wolters Kluwer Health, told MobiHealthNews in an email.
“Using generative AI to search and retrieve the most relevant and current medical information can allow clinicians to be much more efficient and effective in finding the critical evidence for their patient’s condition,” Samios said.
He adds that this is particularly important as providers seek ways to reduce their administrative and cognitive burden.
“We are building AI Labs on the same UpToDate content the global healthcare community has trusted and depended on for over 30 years,” Samios explains. “This provides our customers with a safe space to experiment with applying generative AI to that content and evaluate its potential for use in clinical care.”
He said he believes the time is ripe for helping clinicians navigate the complexities of healthcare by creating answers and recommendations using these new technologies that are trustworthy and efficient.
The Waltham, Massachusetts-based company’s design, development and deployment of the feature was aided by its AI Principles, which focus on data privacy and security, governance and accountability, and transparency and explainability.
THE LARGER TREND
The interest in AI in healthcare has been turbocharged by the emergence of generative AI technologies, which have the potential to streamline operations for healthcare professionals across several applications.
Tech giant Microsoft recently announced a long-term partnership with multistate healthcare system Mercy, which will utilize its Azure OpenAI Service to provide generative AI-assisted communication resources to patients and Mercy employees.
Komodo Health launched the AI-enabled MapLab, which provides information on treatment pathways, disease trends and patient populations for life sciences and healthcare companies.
Meanwhile, GE HealthCare received $44 million from the Bill and Melinda Gates Foundation to develop AI-enabled ultrasound technology for maternal care and pediatric lung health in low- and middle-income countries.
This story originally appeared on MobiHealthNews
